Mr. CEO Goes to Washington

Jan. 11 (Bloomberg) -- It's crippled by debt and ruled by gridlock. If it were a company, would you invest in Congress? We'll ask a former CEO now bringing his business experience to Capitol Hill. As the only member of the House to serve as CEO of a publicly traded company, newly elected Rep. John Delaney (D-MD) hopes to put his business skills to work in the halls of Congress. (Source: Bloomberg)

Will Acquiring Allergan Impact Pfizer's R&D?
36:55 - Dr. Beth Seidenberg, Kleiner Perkins Caufield & Byers general partner, discusses the financial implications of the Pfizer-Allergan deal. She speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • How to Manage the Hype in Tech Startups
  • Yuan Addition to SDR to Draw Inflows to China: Pihlman
  • U.S. Markets: What Caused Today's Weakness?